Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effect of Diflunisal on Familial Amyloidosis
This study is currently recruiting participants.
Study NCT00294671   Information provided by Boston University
First Received: February 21, 2006   Last Updated: July 30, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Familial Amyloid Polyneuropathy
Familial Amyloidosis
Additional conditions recognized in this trial
Amyloid Neuropathies
Amyloid Neuropathies, Familial
Amyloidosis
Amyloidosis, Familial
Polyneuropathies
More general conditions related to this trial
Genetic Diseases, Inborn
Heredodegenerative Disorders, Nervous System
Metabolic Diseases
Metabolism, Inborn Errors
Nervous System Diseases
Neurodegenerative Diseases
Neuromuscular Diseases
Peripheral Nervous System Diseases
Interventions listed in this trial
diflunisal
placebo
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Boston University
Food and Drug Administration (FDA)
National Institute of Neurological Disorders and Stroke (NINDS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services